NCT02173405 - Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2014

Primary Completion Date

September 1, 2015

Study Completion Date

September 1, 2016

Conditions

Myofascial Pain SyndromesMyofascial Trigger Point PainTrigger Point Pain, Myofascial

Interventions

DRUG

OnabotulinumtoxinA

comparison of OnabotulinumtoxinA with placebo

DRUG

Placebo

comparison of placebo with investigational drug OnabotulinumtoxinA

Trial Locations (3)

University Case Medical Center, Cleveland

University Hospitals Landerbrook Health Center, Urology, Mayfield Heights

University Hospitals Westlake Health Center, Urology, Westlake